InSite Vision Incorporated of Alameda, CA has out-licensed to Essex Bio-Technology Limited the China rights for AzaSite® (azithromycin ophthalmic solution) 1%, an antiseptic eye drop. Essex will be responsible for securing SFDA approval of the product as a treatment for ocular bacterial infection. Essex is listed on the Growth Enterprise Market (GEM) of the Hong Kong Exchange. More details...

Stock Symbols: (AMEX: ISV) (HK: 8151)